Related Experiment Video

Updated: Aug 12, 2026

Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis
06:09

Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis

Published on: July 18, 2017

Oesophageal pyomyositis in an intravenous drug user

Frank Cheau-Feng Lin1, Kee-Ching Jeng2, Stella Chin-Shaw Tsai3

  • 1Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan Department of Thoracic Surgery, Chung Shan Medical University Hospital, Taichung, Taiwan.

Interactive Cardiovascular and Thoracic Surgery
|August 16, 2014
PubMed

Insights

Oesophageal pyomyositis, a rare bacterial infection of the esophagus, can be challenging to diagnose. This case highlights early CT scans and prompt treatment for successful outcomes in intravenous drug users.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Medical Imaging

Background:

  • Oesophageal inflammatory or infectious diseases affecting deeper tissue layers can be diagnostically challenging.
  • Bacterial pyomyositis typically affects skeletal muscle; gastrointestinal involvement is exceptionally rare and often misdiagnosed due to nonspecific symptoms.

Observation:

  • A case of oesophageal pyomyositis in an intravenous drug user is presented.
  • The patient exhibited nonspecific clinical features, complicating initial diagnosis.

Findings:

  • Early computed tomography (CT) imaging was crucial for accurate diagnosis of oesophageal pyomyositis.
  • A treatment regimen involving adequate drainage and antibiotic therapy proved effective.

Implications:

  • This case underscores the importance of considering rare diagnoses like oesophageal pyomyositis in at-risk populations.
  • Prompt diagnosis and intervention can lead to successful treatment and preservation of the oesophagus.
  • This report represents the first documented instance of oesophageal myositis in an intravenous drug user.
Keywords:
OesophagusPyomyositis

More Related Videos

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices02:14

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices

Published on: August 1, 2025

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...